Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Terminated 6

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 16Thoracic 6Lymphoid 5Genitourinary 5Gastrointestinal 5Tumor-Agnostic 2Sarcoma 2Gynecologic 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Endocrine 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × antineoplaston AS 2-1 × Thoracic × Clear all
NCT00003508 2021-04-27

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Burzynski Research Institute

Phase 2 Terminated
8 enrolled 5 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00003492 2020-12-16

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
9 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003497 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00003491 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
17 enrolled
Thoracic

Lung Neoplasms

NCT00003495 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
7 enrolled
Thoracic

Lung Neoplasms

NCT00003496 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
4 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡